Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
United-Guardian
UG
$33.1M
| $76.4K | ﹤0.01% |
+10,609
| New | +$77.4K |
|
11452
SEALSQ Corp
LAES
$581M
| $76.2K | ﹤0.01% |
59,539
+70
| +0.1% | +$91 |
|
|
DNMR
11453
DELISTED
Danimer Scientific, Inc.
DNMR
| $76K | ﹤0.01% |
1,863
+253
| +16% | +$13.8K |
|
|
KC
11454
PUT
Kingsoft Cloud Holdings
KC
$3.17B
| $76K | ﹤0.01% |
20,100
-92,900
| -82% | -$424K |
|
11455
Nuveen Multi-Market Income Fund
JMM
$54.9M
| $75.8K | ﹤0.01% |
+12,827
| New | +$72.2K |
|
11456
PUT
Upland Software
UPLD
$13.7M
| $75.7K | ﹤0.01% |
1,790
+660
| +58% | +$28.5K |
|
11457
CALL
Conduent
CNDT
$271M
| $75.6K | ﹤0.01% |
20,700
-96,600
| -82% | -$306K |
|
|
BPT
11458
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $75.4K | ﹤0.01% |
30,544
-177
| -0.6% | -$719 |
|
11459
Enlivex Ltd
ENLV
$25.9M
| $75.4K | ﹤0.01% |
+1,862
| New | +$47.4K |
|
11460
Century Therapeutics
IPSC
$404M
| $75.1K | ﹤0.01% |
+22,629
| New | +$41.2K |
|
11461
Riskified
RSKD
$808M
| $75.1K | ﹤0.01% |
16,047
-30,826
| -66% | -$126K |
|
|
KZR
11462
CALL
DELISTED
Kezar Life Sciences
KZR
| $74.9K | ﹤0.01% |
7,880
| – | – |
|
|
LNAI
11463
CALL
Lunai Bioworks
LNAI
$10.7M
| $74.8K | ﹤0.01% |
295
-280
| -49% | -$76.7K |
|
11464
Envela
ELA
$362M
| $74.6K | ﹤0.01% |
15,356
-36,876
| -71% | -$158K |
|
|
EGIO
11465
CALL
DELISTED
Edgio, Inc. Common Stock
EGIO
| $73.9K | ﹤0.01% |
5,435
+715
| +15% | +$17.6K |
|
11466
American Express Global Business Travel
GBTG
$4.94B
| $73.8K | ﹤0.01% |
11,444
-10,015
| -47% | -$57.1K |
|
11467
GEE Group
JOB
$27.9M
| $73.5K | ﹤0.01% |
146,886
+59,127
| +67% | +$32.2K |
|
11468
CALL
Maravai LifeSciences
MRVI
$1.25B
| $73.4K | ﹤0.01% |
11,200
-93,900
| -89% | -$607K |
|
11469
Foghorn Therapeutics
FHTX
$369M
| $73.1K | ﹤0.01% |
11,331
-20,007
| -64% | -$86.3K |
|
|
ZFOX
11470
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $73.1K | ﹤0.01% |
84,000
+63,118
| +302% | +$43.2K |
|
11471
VirnetX Holding Corp
VHC
$52.8M
| $73K | ﹤0.01% |
10,435
+8,342
| +399% | +$53.4K |
|
|
MESO
11472
CALL
Mesoblast
MESO
$2.36B
| $73K | ﹤0.01% |
33,200
-21,850
| -40% | -$52.1K |
|
11473
PUT
The Honest Company
HNST
$618M
| $72.9K | ﹤0.01% |
22,100
+4,400
| +25% | +$8.02K |
|
11474
PUT
Corvus Pharmaceuticals
CRVS
$1.24B
| $72.9K | ﹤0.01% |
41,400
-12,000
| -22% | -$17.5K |
|
11475
Precipio
PRPO
$52.4M
| $72.9K | ﹤0.01% |
11,509
+353
| +3% | +$2.48K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.